Muir-Torre phenotype has a frequency of DNA mismatch-repair gene mutations similar to that in hereditary nonpolyposis colorectal cancer families defined by the Amsterdam criteria

被引:169
作者
Kruse, R
Rütten, A
Lamberti, C
Hosseiny-Malayeri, HR
Wang, YP
Ruelfs, C
Jungck, M
Mathiak, M
Ruzicka, T
Hartschuh, W
Bisceglia, M
Friedl, W
Propping, P
机构
[1] Univ Bonn, Inst Human Genet, D-53111 Bonn, Germany
[2] Univ Bonn, Dept Gen Internal Med, D-53111 Bonn, Germany
[3] Univ Bonn, Inst Pathol, D-53111 Bonn, Germany
[4] Lab Dermatohistopathol, Friedrichshafen, Germany
[5] Univ Dusseldorf, Dept Dermatol, D-4000 Dusseldorf, Germany
[6] Univ Heidelberg, Dept Dermatol, D-6900 Heidelberg, Germany
[7] Casa Sollievo della Sofferenza Hosp, Dept Anat Pathol, Foggia, Italy
关键词
D O I
10.1086/301926
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Muir-Torre syndrome (MTS) is an autosomal dominant disease defined by the coincidence of at least one sebaceous skin tumor and one internal malignancy About half of MTS patients are affected by colorectal cancer. In a subgroup of MTS patients the disease has an underlying DNA mismatch-repair (MMR) defect and thus is allelic to hereditary nonpolyposis colorectal cancer (HNPCC). The purpose of this study was to examine to what extent germ-line mutations in DNA MMR genes are the underlying cause of the MTS phenotype. We ascertained 16 MTS patients with sebaceous skin tumors and colorectal cancer, and we examined their skin and visceral tumors for microsatellite instability. All the patients exhibited high genomic instability in at least one tumor. The search for germ-line mutations in the hMSH2 and hMLH1 genes in 13 of the MTS patients revealed truncating mutations in 9 (69%): eight mutations in the hMSH2 gene and one in the hMLH1 gene. This is the first systematic search for germ-line mutations in patients ascertained on the basis of sebaceous skin tumors. Our results indicate that (1) MTS patients exhibit significantly more mutations in the hMSH2 gene than in the hMLH1 gene; and (2) the subpopulation of MTS patients who are also affected by colorectal cancer, irrespective of family history and age at onset of tumors, may have a likelihood for an underlying DNA MMR defect similar to that for patients with a family history fulfilling the strict clinical criteria for HNPCC.
引用
收藏
页码:63 / 70
页数:8
相关论文
共 30 条
  • [1] Bapat B, 1996, AM J HUM GENET, V59, P736
  • [2] MUIR-TORRE SYNDROME - A CASE-REPORT
    BISCEGLIA, M
    ZENAROLA, P
    [J]. TUMORI, 1991, 77 (03) : 277 - 281
  • [3] Bocker T, 1997, CANCER RES, V57, P4739
  • [4] MUIR-TORRE SYNDROME - HISTOLOGIC SPECTRUM OF SEBACEOUS PROLIFERATIONS
    BURGDORF, WHC
    PITHA, J
    FAHMY, A
    [J]. AMERICAN JOURNAL OF DERMATOPATHOLOGY, 1986, 8 (03) : 202 - 208
  • [5] COHEN PR, 1991, AM J MED, V90, P606
  • [6] Muir-Torre syndrome: Clinical features and molecular genetic analysis
    Esche, C
    Kruse, R
    Lamberti, C
    Friedl, W
    Propping, P
    Lehmann, P
    Ruzicka, T
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 1997, 136 (06) : 913 - 917
  • [7] SINGLE-STEP SCREENING METHOD FOR THE MOST COMMON MUTATIONS IN FAMILIAL ADENOMATOUS POLYPOSIS
    FRIEDL, W
    MANDL, M
    SENGTELLER, M
    [J]. HUMAN MOLECULAR GENETICS, 1993, 2 (09) : 1481 - 1482
  • [8] MUIR-TORRE SYNDROME - A VARIANT OF THE CANCER FAMILY SYNDROME
    HALL, NR
    WILLIAMS, MAT
    MURDAY, VA
    NEWTON, JA
    BISHOP, DT
    [J]. JOURNAL OF MEDICAL GENETICS, 1994, 31 (08) : 627 - 631
  • [9] MUIR-TORRE SYNDROME - DIAGNOSTIC-CRITERIA AND REVIEW OF THE LITERATURE
    HARTIG, C
    STIELER, W
    STADLER, R
    [J]. HAUTARZT, 1995, 46 (02): : 107 - 113
  • [10] HONCHEL R, 1994, CANCER RES, V54, P1159